Home Wires popular

popular wires

Buy Hold Sell

Buy Hold Sell: 3 ASX stocks the market loves (and 2 that are flashing red)

In this episode, David Keelan from Ellerston and Andrew Peros from Ausbil analyse a handful of the ASX's market darlings.
360
AD8
+2
Buy Hold Sell
Livewire Markets
The Pitch

How a gap in the banking sector is generating returns

Why Apollo Global Management sees opportunity in a regulation-driven funding gap.
Sara Allen
Livewire Markets
The Pitch

Bob Desmond: We are close to euphoria - here's what that means for investors

Claremont Global's Bob Desmond believes investors should be ready to take advantage of opportunities should a pullback occur.
+1
Ally Selby
Livewire Markets
Investment Theme

Where the investment signals lie amid a plethora of noise

There may be significant uncertainty around the political framework but structural investment opportunities still abound.
Bennelong Funds Management
Fund Manager
Macro

Playing the American exceptionalism story

Sitting down to their Thanksgiving dinners this week many American investors may be asking themselves whether they can simultaneously have their pumpkin pie and eat...
Tom Stevenson
Fidelity International
Equities

Trump trades are chump trades

Following the crowd into a Trump Trade like Tesla will end in tears. Here are three lessons for surviving Trump's next term for investors.
Charles Ormond
Fat Tail Investment Research
Asset Allocation

Key implications of Trump 2.0 for Private Equity

We remain optimistic about private equity’s ability to navigate change in a dynamic environment
Neuberger .
Neuberger
Property

Mezzanine finance and the risk of 'over-leveraging’ property exposures

Clive Smith takes a closer look at the role of mezzanine finance as a funding source for property development and the risk of overleverage.
Clive Smith
Education

Media worth consuming – November 2024

Interesting and under the radar media on finance, economics, politics and society
Jonathan Rochford
Narrow Road Capital
The Pitch

Is it time to sell your ASX consumer stocks?

Fidelity International's Casey McLean certainly thinks so. Hear why in this episode of The Pitch.
Hans Lee
Livewire Markets
Commodities

Booming bauxite the metal of 2024 as tight supplies meet import-reliant China

Metro and Arrow among the few ASX stocks offering leveraged exposure; Plus, Spartan and Rumble take the week’s gold honours.
MMI
RIO
+3
Barry FitzGerald
Independent Journalist
Commodities

UBS: The bullion bull run is set to continue (and the 5 ASX stocks they like most)

We unpack UBS' bullish thesis for gold, and leverage insights from Livewire to assess the five stocks it likes.
DEG
+2
Chris Conway
Livewire Markets
Equities

Here comes Santa! Can we expect ASX shares to soar to record highs in December?

Time flies when you’re having fun! ASX stocks enter December, traditionally one of the strongest months of the year, in strong shape.
BHP
BKW
+17
Carl Capolingua
Livewire Markets
Weekend Report

Trending On Livewire: Weekend Edition - Saturday 30th November

ASX 200 reached record highs this week, fueled by small and mid-cap gains, signaling strong momentum into year-end.
Livewire Exclusive
Livewire Markets
Buy Hold Sell

Buy Hold Sell: 5 of the ASX's fastest growing small caps

In this episode, David Keelan from Ellerston and Andrew Peros from Ausbil analyse some of the ASX's top small caps.
+7
Buy Hold Sell
Livewire Markets
Investment Theme

10 reasons why the crisis facing Gautam Adani, Asia's second richest man, may not be over yet

Its troubles may be over for now but a US$55 billion belting in its share price suggests investors have already made up their mind.
GQG
Hans Lee
Livewire Markets
Buy Hold Sell

Could these 2 stocks become the ASX's next 10-baggers?

You'll find out in this episode of Buy Hold Sell.
360
+9
Buy Hold Sell
Livewire Markets
Fund in Focus
Sponsored

Seneca's 3 underrated small caps for 2025

In this Fund in Focus, you'll learn where Seneca's Luke Laretive is finding out-of-love small-cap stocks on the ASX.
MP1
+1
Ally Selby
Livewire Markets
Equities

Double digit growth at a discount, is this an overlooked mega cap?

Why we see value in this monopoly business that is trading at a discount to the market and its peers.
James Rodda
Antipodes
Equities

The ASX-listed Biotech set to unlock significant value

This $60m ASX-listed biotech, with a cutting-edge pipeline of transformative therapies, stands at a key inflection point for value creation.
CSL
PXS
+1
Hashan De Silva
KP Rx
4241-4260 of 39311